Top Abstract Purchase Related
Home
>
Node
>
Subnode

The role of alpha 1-proteinase inhibitor in semisoluble glucan induced resistance to hemorrhage

Vereschagin, E.I.; Korolenko, T.A.; Arkhipov, S.A.

Agents and Actions. Supplements 38: 385-388

1992

ISSN/ISBN: 0379-0363
PMID: 1462871
Document Number: 389536
The present study was undertaken to evaluate the mechanism of protective effect of semisoluble beta-1,3-carboxymethylglucan (CMG) during acute massive hemorrhage. CBA mice were injected i.v. with glucan (25 mg/kg) 24 h prior to hemorrhage (50% of blood circulating volume). Survival data indicated that glucan increased survival compared with control. However, alpha 1-proteinase inhibitor activity in serum have been even decreased 24 h after glucan administration. Moreover enhancement of active oxygen form production and leakage of cytosol and lysosomal enzymes after CMG application were noted.

Document emailed within 1 workday
Secure & encrypted payments

Kohli, V.; Singh, S. 1990: Role of elastase-alpha-1 proteinase inhibitor in early diagnosis of neonatal sepsis Indian Pediatrics 27(8): 880-881
Kimpen, J.; Legius, E.; Bosmans, E.; Van Vaerenbergh, V.; Ramon, A.; Raus, J. 1990: Alpha-1-proteinase inhibitor gene frequencies in Belgium Gene Geography: a Computerized Bulletin on Human Gene Frequencies 4(3): 159-163
Speer, C.P.; Ninjo, A.; Gahr, M. 1986: Elastase-alpha 1-proteinase inhibitor in early diagnosis of neonatal septicemia Journal of Pediatrics 108(6): 987-990
Lee, D.; Shochat, D.; Gold, D.V. 1982: Alpha 1-Proteinase inhibitor production by human adenocarcinomas xenotransplanted into nude mice Journal of the National Cancer Institute 69(2): 381-385
El Yamani, J.; Hayem, A.; Lafitte, J.J.; Gressier, B.; Mizon, J. 1986: Functional and immunoreactive alpha 1 proteinase inhibitor in bronchoalveolar lavages: methodological studies Bulletin Europeen de Physiopathologie Respiratoire 22(4): 359-363
Asami, T.; Nishihara, T.; Fujii, M.; Sakai, K. 1989: Decreased plasma alpha 1-proteinase inhibitor activity in idiopathic nephrotic syndrome Nihon Jinzo Gakkai Shi 31(3): 301-307
Travis, J.; Beatty, K.; Wong, P.S.; Matheson, N.R. 1980: Oxidation of alpha 1-proteinase inhibitor as a major, contributing factor in the development of pulmonary emphysema Bulletin Europeen de Physiopathologie Respiratoire 16(Suppl): 341-352
Ohno, H. 1991: The role of proteinase inhibitor on the regulation of proteolysis Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 1972-1977
Schoenfeld, N.; Schmitt, M.; Remy, N.; Wahn, U.; Loddenkemper, R. 1993: Studies on lymphocyte characteristics in patients with homozygous alpha 1-proteinase inhibitor deficiency during substitution therapy Monaldi Archives for Chest Disease 48(6): 613-616
Laurent, P.; Bieth, J.G. 1985: Cigarette smoke decreases the rate constant for the association of elastase with alpha 1-proteinase inhibitor by a non-oxidative mechanism Biochemical and Biophysical Research Communications 126(1): 275-281
Renesto, P.; Chignard, M. 1994: Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor Journal of Laboratory and Clinical Medicine 123(6): 906-913
Mitichkina, E.V.; Morozov, S.G.; Zakharova, I.A.; Volkova, E.N.; Elistratova, I.V. 2014: Leukocyte elastase, alpha 1-proteinase inhibitor and C-reactive protein in patients with delayed negativation of serological reactions after treatment of early syphilis Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 8-12
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679
Grabowska-Bochenek, R.; Drózdz, M.; Kopieczna-Grzebieniak, E.; Piekarski, M. 1990: Concentration of some proteinase inhibitors: alpha 1-antitrypsin and alpha 2-macroglobulin in rabbit blood serum in two models of experimental atherosclerosis Acta Biochimica Polonica 37(1): 125-127
Fukuda, C.; Iijima, K.; Inoue, N.; Takashima, Y.; Urabe, C.; Nakamura, K. 1988: Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery Rinsho Byori. Japanese Journal of Clinical Pathology 36(3): 346-350
Aoki, N. 1993: Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin Thrombosis and Haemostasis 70(2): 376
Secchi, A.G.; Carli, A. 1971: Action of a proteinase inhibitor in experimental uveitis Annali di Ottalmologia E Clinica Oculistica 97(2): 41-46
Soman, G.; Philip, G. 1976: Purification and properties of alpha-glucan phosphorylase b from Indocibium guttattam Indian Journal of Biochemistry and Biophysics 13(3): 202-207
Chaube, R.; Joy, K.P. 2010: Inhibition of hCG-induced spawning by alpha-methylparatyrosine, a tyrosine hydroxylase inhibitor, in the catfish Heteropneustes fossilis (Bloch) Indian Journal of Experimental Biology 48(6): 549-553
Krappmann, D.; Wulczyn, F.G.; Scheidereit, C. 1996: Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo EMBO Journal 15(23): 6716-6726